Back to results
US 8,278,452 B2Granted
Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors
AssigneeIrm LLC
InventorsDonatella Chianelli, Xiaolin Li, Xiaodong Liu, Jon Loren, Valentina Molteni, Juliet Nabakka, Vince Yeh
Life of this patent
Estimating the term…
Abstract
The invention provides a novel class of compounds of Formula I: (I) pharmaceutical compositions comprising such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFRβ kinases.
Claims14
A compound of Formula I:
- in which
- R1 is selected from halo, C1-6alkyl, C3-12cycloalkyl, C3-8heterocycloalkyl, C6-10aryl and C3-10heteroaryl;
- wherein said C1-6alkyl of R1 is optionally substituted with 1 to 3 radicals independently selected from halo, hydroxy, cyano, nitro, ═N(OH), C1-4alkoxy and benzoxy;
- wherein said cycloalkyl, heterocycloalkyl, aryl or heteroaryl of R1 is optionally substituted with 1 to 3 radicals independently selected from halo, hydroxy, cyano, nitro, C1-6alkyl, halo-substituted-C1-6alkyl, hydroxy-substituted-C1-6alkyl, C1-6alkoxy, halo-substituted-C1-6alkoxy, —X1NR3aR3b, —X1C(O)R3a, —X1C(O)OR3a, —X1OR3a, C3-12cycloalkyl, C3-8heterocycloalkyl, C6-10aryl and C3-10heteroaryl;
- wherein X1 is selected from a bond and C1-4alkylene;
- wherein R3a and R3b are independently selected from hydrogen and C1-6alkyl;
- R2 is selected from methyl and ethyl;
- A is 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,4-triazolyl, 1,2-oxazolyl, 1,2,4-thiadiazolyl or 1,3,4-thiadiazolyl;
- wherein the oxadiazolyl, triazolyl, isoxazolyl and thiadiazolyl of A can be optionally substituted with C1-2alkyl;
- or the pharmaceutically acceptable salts thereof.
7 more elements
Dependencies are inferred from the claim text.